no of cryptocurrency Top stories

Yuncong Technology: "The R&D team of large-scale model agent products is basically dissolved" is all false information. Yuncong Technology said on the interactive platform that the company's R&D team is stable at present, and a rigorous and meticulous hierarchical division of labor system has been established for the research and development of large-scale model related products. The configuration of R&D echelon will be flexibly adjusted according to the continuous evolution of large model technology and the changes of market demand of agent products. The statements of "the No.1 position of the big model algorithm" and "the R&D team of the big model agent product is basically dissolved" mentioned in the question are false information, and the company reserves the right to pursue legal responsibility for this. The company has been unswervingly promoting the research and product development of large-scale model and agent-related technologies.Ministry of Health of Gaza: Since October 7, 2023, 44,835 Palestinians have been killed and 106,356 injured in Israeli military attacks on the Gaza.18 shares were rated by brokers, and Yuhetian's target increased by 54.72%. On December 11th, a total of 18 shares were rated by brokers, and 6 of them announced their target prices. According to the highest target price, Yuhetian, Steady Medical Care and Fulongma ranked in the top, with increases of 54.72%, 19.96% and 17.62% respectively. Judging from the direction of rating adjustment, the ratings of 12 stocks remain unchanged and 6 stocks are rated for the first time. In addition, one stock attracted the attention of many brokers, and Hagrid Communications was ranked in the top number, with two brokers rating it respectively. Judging from the Wind industry to which the rated stocks are bought, the number of rated stocks for technical hardware and equipment, capital goods and materials II is the largest, with 4, 3 and 2 respectively.

Jianfan Bio: The plasma separator was certified by the European Union MDR, and Jianfan Bio announced that Jianfan Blood Purification Company, a wholly-owned subsidiary, recently received a notice from the EU announcement agency that its plasma separator was certified by the European Union MDR in accordance with the EU Medical Devices Regulation 2017/745, and can be sold in EU countries and other countries that recognize the EU CE certification.The governor of the Swiss National Bank once again threatened negative interest rates, saying that it really worked. Martin Schlegel, governor of the Swiss National Bank, said that the bank did not like negative interest rates, but would use them again when necessary to curb speculation in the Swiss franc. Before his speech, the Swiss National Bank unexpectedly cut interest rates by 50 basis points. The new central bank governor once again threatened to re-implement the negative interest rate policy if necessary. "Nobody likes negative interest rates, and neither does the Swiss National Bank," Schlegel told Bloomberg Television in Bern. "Of course, we will also be ready to implement negative interest rates again if necessary. But as we cut interest rates today, the possibility of negative interest rates has been reduced. "Yuncong Technology: "The R&D team of large-scale model agent products is basically dissolved" is all false information. Yuncong Technology said on the interactive platform that the company's R&D team is stable at present, and a rigorous and meticulous hierarchical division of labor system has been established for the research and development of large-scale model related products. The configuration of R&D echelon will be flexibly adjusted according to the continuous evolution of large model technology and the changes of market demand of agent products. The statements of "the No.1 position of the big model algorithm" and "the R&D team of the big model agent product is basically dissolved" mentioned in the question are false information, and the company reserves the right to pursue legal responsibility for this. The company has been unswervingly promoting the research and product development of large-scale model and agent-related technologies.

Jianfan Bio: The plasma separator was certified by the European Union MDR, and Jianfan Bio announced that Jianfan Blood Purification Company, a wholly-owned subsidiary, recently received a notice from the EU announcement agency that its plasma separator was certified by the European Union MDR in accordance with the EU Medical Devices Regulation 2017/745, and can be sold in EU countries and other countries that recognize the EU CE certification.OPENAI said that it is working hard to solve the current fault problem.World Gold Council: The price of gold is expected to hit its best annual performance in more than 10 years. It is expected that there will be a positive but moderate growth next year. According to the report of the World Gold Council, the price of gold is expected to hit its best annual performance in more than 10 years, with an increase of 28% as of November. Behind this, the purchases of the central bank and investors offset the significant slowdown in consumer demand. Looking ahead, all eyes are focused on the impact of Trump's second term on the global economy. The current forecast of GDP, yield and inflation shows that gold will have a positive but much more moderate growth in 2025. The upward trend may benefit from a sharp drop in interest rates, an increase in volatility, or the continuous higher-than-average demand for gold by the central bank. On the contrary, higher long-term interest rates or weak demand for gold consumption may bring headwinds.